Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Envestors secures Cherrygood funding

8 Dec 2011 07:00

RNS Number : 5550T
Braveheart Investment Group plc
08 December 2011
 



8 December 2011

 

Braveheart Investment Group plc

("Braveheart" or the "Group")

 

Envestors secures £882,000 equity funding for Cherrygood

 

Braveheart (AIM: BRH), the AIM-listed specialist in growth capital investments for business angels, high net worth individuals and family offices, announces that Envestors Limited, its wholly owned subsidiary, has closed a £882,000 equity fundraising for Cherrygood Limited.

 

Cherrygood is a fast-growing juice brand in the UK, selling in Tesco, Asda, Sainsbury's, Morrisons and Waitrose, and is expanding rapidly through increased distribution and the launch of new products. Developed to capitalise on the global trend of health and wellbeing that is driving innovation in the food and drink sector, Cherrygood aims to be the global cherry brand of choice.

 

Cherrygood's Montmorency cherries offer significant health benefits including very high antioxidant levels. They are rich in melatonin and used to aid muscle recovery. Cherrygood is consumed by Olympic athletes and other sports people.

 

Scott Haughton, Founder Director of Envestors, said: "We believe this business has significant global growth potential."

 

John Heseltine, Managing Director of Cherrygood, who previously founded the UK juice bar brand Lovejuice, said: "The money will be used to grow market share in the UK and to continue growth in Europe, the Middle East and the US, specifically, to strengthen the commercial team and support the launch of new products."

 

 

Further information:

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive

gthomson@braveheart-ventures.co.uk

Tel: 01738 587555

 

Seymour Pierce Limited

Freddy Crossley (Nominated Adviser)

Paul Jewell, David Banks (Corporate Broking)

Tel: 020 7107 8000

 

 

Envestors Limited

Scott Haughton, Founder Director

scott@envestors.co.uk

Tel: 020 7240 0202

 

Cherrygood Limited

John Heseltine, Managing Director

john@cherrygood.com / www.cherrygood.com

Tel: 020 7251 9924

 

 

Media enquiries:

 

Allerton Communications

Peter Curtain

peter.curtain@allertoncomms.co.uk

Tel: 020 3137 2500

Notes to Editors

Braveheart Investment Group plc

 

Braveheart Investment Group makes and manages investments in young, emerging British companies, specialising in building tax efficient portfolios for business angels, high net worth individuals and family offices. Braveheart has a demonstrable track record in investing, an established client base and various funds under management. The Group has offices in Perth, London, Yorkshire and Jersey with franchise operations in Dubai and Manchester.

 

Following the 2010 acquisition of Envestors Limited, the London based specialist corporate finance advisory business, Braveheart offers a unique and comprehensive suite of tax efficient products to high net worth investors.

 

For more information: www.braveheartinvestmentgroup.co.uk

 

Envestors Limited

 

Envestors enables investors to source dynamic unquoted companies in need of growth capital. Comprising more than 1,000 fee-subscribed private investors, 14 family offices and a range of funds and venture capital sources, its network has helped over 65 companies raise in excess of £25 million, the majority of opportunities attracting taxation benefits under the Enterprise Investment Scheme (EIS).

 

Services to companies include intensive preparation for fundraising, initial due diligence and screening, facilitating corporate fundraising through in-demand investor presentation events and face-to-face meetings with potential investors, and placing of non-executive talent.

 

Envestors was awarded the "Private Investor Network of the Year" at Investor Allstars in 2009 and again in 2011 and is a subsidiary of Braveheart Investment Group plc.

 

For more information: www.envestors.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLBDDIBGBGBR
Date   Source Headline
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSPortfolio update - Proposed sale of Phasefocus
15th Dec 202311:41 amRNSInvestment update - Paraytec Limited
15th Dec 202310:16 amRNSReplacement: Half-year Report
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSInvestment update - Paraytec Limited
14th Nov 20239:02 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSInvestment update – Paraytec Limited
10th Oct 202311:15 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSInvestment update – Kirkstall Limited
8th Sep 20237:00 amRNSBlock admission six monthly return
21st Aug 20237:00 amRNSFurther investment in Phasefocus Holdings Limited
28th Jul 20232:25 pmRNSInvestment update on Paraytec Limited
28th Jul 202311:54 amRNSResult of AGM
5th Jul 20237:00 amRNSPosting of annual report and notice of AGM
4th Jul 20237:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
31st May 20237:00 amRNSInvestment update – Phasefocus Holdings Limited
3rd May 20237:00 amRNSUpdate on investments
24th Apr 202310:49 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of options
13th Mar 20239:34 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSBlock admission six monthly return
10th Feb 20231:26 pmRNSHolding(s) in Company
30th Jan 20234:37 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSOperational update
22nd Dec 20229:14 amRNSHolding(s) in Company
19th Dec 20229:25 amRNSDirector/PDMR Shareholding
19th Dec 20229:11 amRNSAcquisition of interest in Image Scan Holdings plc
13th Dec 20224:37 pmRNSHolding(s) in Company
15th Nov 20223:09 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Oct 20227:00 amRNSHalf-year Report
21st Oct 202210:33 amRNSHolding(s) in Company
20th Oct 20221:59 pmRNSAcquisition of further interest in Autins
5th Oct 20223:15 pmRNSHolding(s) in Company
5th Oct 202212:28 pmRNSAcquisition of further interest in Aukett Swanke
30th Sep 20225:00 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSPlacing and subscription to raise £750,000
9th Sep 20227:00 amRNSBlock admission six monthly return
6th Sep 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.